Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 5/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3265084 | 1.00 | TYMS (0.71) | TYMS | |
| SCHEMBL6462543 | 0.90 | POLB (0.62) | TYMS | |
| SCHEMBL149769 | 0.90 | POLB (0.62) | TYMS | |
| Thymidine Monophosphate SCHEMBL8366987 | 0.88 | POLB (0.80) | TYMS | |
| 5-Fluorodeoxyuridylate SCHEMBL21901970 | 0.88 | LMNA (0.71) | TYMS | |
| Thymidine Monophosphate SCHEMBL16280929 | 0.88 | POLB (0.80) | TYMS | |
| 5-Fluorodeoxyuridylate SCHEMBL15189164 | 0.88 | LMNA (0.71) | TYMS | |
| Thymidine Monophosphate SCHEMBL3984895 | 0.88 | POLB (0.80) | TYMS | |
| 5-Fluorodeoxyuridylate SCHEMBL973436 | 0.88 | LMNA (0.71) | TYMS | |
| SCHEMBL335865 | 0.88 | TYMS (0.74) | TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| WO-2010022454-A1 | METHODS, PRIMERS AND KITS FOR GENOTYPING NEOSPORA SPECIES AND STRAINS | UNIVERSITY OF TECHNOLOGY, SYDNEY (AU) | 2010-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | TYMS 3277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.